CLINICAL_TRIALS
research
· 2024-06-27
Clinical Trial Update: L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma [Phase 1]
Summary
Phase 1 clinical trial evaluating L218CAR19 in relapsed or refractory B-cell lymphoma, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Henan Cancer Hospital | Conditions: Relapsed/Refractory B-cell Lymphomas | Phase 1 | Status: RECRUITING